CITIGROUP INC - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$2,0000.0%2,9900.0%0.00%
Q1 2017$2,000
+100.0%
2,9900.0%0.00%
Q4 2016$1,0000.0%2,990
-7.7%
0.00%
Q3 2016$1,0000.0%3,2400.0%0.00%
Q2 2016$1,000
-98.8%
3,240
-98.3%
0.00%
Q1 2016$81,000
+8.0%
193,035
+203.7%
0.00%
Q4 2015$75,000
+2400.0%
63,558
+1841.9%
0.00%
Q3 2015$3,000
-62.5%
3,273
-46.9%
0.00%
Q2 2015$8,000
-73.3%
6,164
-72.2%
0.00%
Q1 2015$30,000
-34.8%
22,212
-32.4%
0.00%
Q4 2014$46,000
+283.3%
32,862
+276.8%
0.00%
Q3 2014$12,000
-33.3%
8,722
-7.4%
0.00%
Q2 2014$18,000
-68.4%
9,418
-68.5%
0.00%
Q1 2014$57,000
-52.5%
29,863
-65.4%
0.00%
Q4 2013$120,000
+2900.0%
86,304
+2663.5%
0.00%
Q3 2013$4,0000.0%3,123
+2.1%
0.00%
Q2 2013$4,0003,0590.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
BAXTER BROS INC 170,506$232,0000.09%
First Heartland Consultants, Inc. 86,204$117,0000.05%
Rotella Capital Management, Inc. 20,769$28,0000.03%
FIDGEON TIMOTHY F 33,000$45,0000.02%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 547,800$746,0000.02%
Freedom Investment Management, Inc. 74,127$101,0000.02%
Investors Capital Advisory Services 63,288$86,0000.02%
REYNOLDS CAPITAL MANAGEMENT LLC 10,000$14,0000.01%
Tower Research Capital LLC (TRC) 76,914$104,0000.01%
PINNACLE FINANCIAL PARTNERS INC 20,000$27,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders